NCT03370939

Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke

Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic stroke-a Prospective Multicenter Registry Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,004 (actual)
• Sponsor: Beijing Tiantan Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Endovascular thrombectomy (EVT) is effective and safe for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) in major clinical trials. Whether the benefit of EVT in randomized trials could be generalized to clinical practice, especially in developing countries, remains unknown. The prospective Chinese ANGEL-ACT Registry (Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke) was established to evaluate the utilization, and subsequent outcomes of EVT treated AIS patients. This study is a multi-center, prospective registry study initiated by researchers, funded by National Key R\&D Program of China. A total of 2,000 patients with acute ischemic stroke will undergo endovascular treatment. The hypothesis was that favorable outcomes from clinical trials could be achieved in clinical practice in China.

Conditions

• Intracranial Artery Occlusion With Infarction (Disorder)

Timeline

• Start date: 2017-11-11
• Primary completion: 2019-07-07
• Completion: 2019-07-07
• First posted: 2017-12-13
• Last updated: 2020-06-01

Locations

1 site across 1 country: China